V. Askanas et al., TWISTED TUBULOFILAMENTS OF INCLUSION-BODY MYOSITIS MUSCLE RESEMBLE PAIRED HELICAL FILAMENTS OF ALZHEIMER BRAIN AND CONTAIN HYPERPHOSPHORYLATED-TAU, The American journal of pathology, 144(1), 1994, pp. 177-187
We immunostained muscle biopsies of 8 patients with sporadic inclusion
body myositis (S-IBM), 7 patients with autosomal recessive hereditary
inclusion body myopathy (H-IBM) (both diseases being characterized by
similar muscle fiber vacuoles containing inclusions), and 11 normal a
nd disease controls. We used the following well-characterized antibodi
es against tau protein: Tau-1, Alz-50, and anti-paired belical filamen
t (PHF) antiserum. By light microscopy, in all S-IBM muscle biopsies v
irtually all vacuoles immunoreactive for ubiquitin and beta-amyloid pr
otein also contained inclusions immunoreactive Alz-50 and anti-PHF ant
iserum. With tau-1 antibody, strong immunoreactivity in the vacuoles w
as obtained only after dephosphorylation of muscle sections. By electr
onmicroscopy, all three antibodies immunodecorated exclusively cytopla
smic twisted tubulofilaments (TTFs). In H-IBM, virtually all ubiquitin
and beta-amyloid-positive muscle fiber vacuoles contained inclusions
immunoreactive with anti-PHF antiserum, but in only 40% of those fiber
s were the inclusions immunoreactive with Alz-50. In six H-IBM patient
s there were no tau-1 immunoreactive inclusions in any of their vacuol
ated muscle fibers; in one patient, 24% of the vacuolated fibers had t
au-1 immunoreactivity. By demonstrating that hyperphosphorylated tau,
which is characteristic of Alzheimer brain PHFs, is a component of S-I
BM-muscle TTFs (which are also ultrastructurally similar to PHFs), our
study: 1) provides the first demonstration of abnormally accumulated
tau in nonneural tissue and 2) suggests that the cytopathogenesis in A
lzheimer brain and S-IBM muscle may share some similar mechanisms. Whe
ther the difference in tau immunoreactivity between S-IBM and most of
the H-IBM patients reflects a difference in genetically determined tra
nscriptional or posttranslational modifications of tau protein or othe
r factors remains to be determined.